ESC 365 - A novel drug candidate targeting the adrenergic regulation of the SERCA2 complex protect the heart from myocardial infarct injury

HFA Premium Access

A novel drug candidate targeting the adrenergic regulation of the SERCA2 complex protect the heart from myocardial infarct injury

Session: ePosters in basic science 3

Topic: Signal Transduction, Mechanotransduction

Speaker: Mrs A. Calejo (Oslo, NO)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Mrs Ana Calejo

Serca Pharmaceuticals, Oslo (Norway)

0 follower

3 more presentations in this session

Single-nuclei sequencing of diabetic cardiomyopathy mouse reveals extent of immune activation and modulated by sacubitril/valsartan

Speaker: Mr N. Karuna (Belfast, GB)

The safety of stem cells transplantation in patients with heart failure from waiting list: focus on latent viral infection

Speaker: Miss A. Esmaeil (Chernivtsi, UA)

Can Troponin-I be an independent predictor of COVID-19 long-term cardiovascular outcomes?

Speaker: Doctor J. Quintal (Setubal, PT)

Access the full session

ePosters in basic science 3

Speakers: Mrs A. Calejo, Mr N. Karuna, Miss A. Esmaeil, Doctor J. Quintal

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by